Shaanxi University of Science and Technology

Xi'an Taikomed Pharmaceutical Technology Co., Ltd.

Shaanxi Panlong Pharmaceutical Co., Ltd.

Yuzhi Liu

Chengyuan Liang

Han Li

Xingke Ju

Lei Tian

Bin Tian

Qianqian Zhao

Dan Yang

Yongbo Wang

Yonghong Tang

Gennian Mao

Nan Hui

Juan Li

Liang Qi

Wenbo Yao

Minghui Chang

Jingwen Xu

Juan Xia

Nan Qin

Xiaolin Xie

Dezhu Zhang

Xuechuan Wang

Danni Tian

Huafeng Qi

Yuanyuan He

Limei Wang

Ning Liu

Shaomeng Pei

Huayin Pu

Mi Wu

Guaiping Qiao

Shunjun Ding

Xuhua Zhou

Zhao Ma

Chunyang Shi

Jie Li

Peiyu Zhou

Jian Zha

Songsong Ruan

Zhenfeng Shi

Jianguo Meng

Zhong Meng

Xuefeng Chen

Kaiqi Shi

Liuyi Yang

Xeufeng Chen

Jian Cha

Juanna Song

Yanghan Liu

Lili Wen

Shujun Ding

A method of preparing a Polygoni Milletii Rhizome tincture includes: preparing a first mixture; extracting the first mixture with 70-90% ethanol under reflux condition to obtain a first extract solution; preparing a second mixture; extracting the second mixture with 50-70% ethanol to obtain a second extract solution; and mixing the first extract solution with the second extract solution to obtain the polygoni milletii rhizome tincture. A method of preparing a Polygoni Milletii Rhizome poultice includes: reparing a Polygoni Milletii Rhizome mixture; mixing the Polygoni Milletii Rhizome mixture and a skin penetration enhancer in water; mixing a moisturizing agent and a binder in water; adding a thickener in water; mixing methylparaben and ethylparaben in 90% ethanol; mixing all solutions to form a mixture; and applying the mixture on a non-woven fabric cloth and drying to form the Polygoni Milletii Rhizome poultice.

Polygoni Milletii Rhizome compositions and methods of preparing the same

A compound having the formula (I): is disclosed. A method of preparing the compound of formula (I) is also disclosed.

Silibinin lipoic acid ester with hepatoprotective activity and a method of preparing the same

A method of inhibiting leukotriene include: administrating a therapeutically effective amount of a compound of chemical formula I or II or a pharmaceutical acceptable salt thereof to a subject, Ris OH or OAc; X is C or N; and Ris H, alkyl, alkoxy, benzyloxy, haloalkyl, OH, CN, NO, or halogen, provided that when X is N, Ris nil.

Methods of using 1-O-acetylbritannilatone spiro aryl isoxazoline compounds

A compound having the formula (I): is disclosed. Methods of preparing the compound of formula (I) are also disclosed. The compound of formula (I) can be prepared by reacting a compound of formula (II) with a compound of formula (III) in an organic solvent with EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide). The compound of formula (I) can also be prepared by reacting the compound of formula (II) with the compound of formula (III) in 1-ethyl-3-methylimidazolium hexafluorophosphate as a solvent with silicomolybdic acid as a catalyst.

Hydroxytyrosol ursolic acid ester with antioxidant activity and methods of preparing the same

Silibinin 3,3'-thiodipropionic acid ester with hepatoprotective activity and a method of preparing the same

A gossypol isatin Schiff base compound with antitumor activities represented by formula I: Rand Rare independently hydrogen, alkyl, cycloalkyl, alkoxy, nitro, halogen, unsubstituted or substituted phenyl, or unsubstituted or substituted benzyl. A method of preparing the compound of formula I is also disclosed.

Gossypol isatin schiff base compounds with antitumor activities and a method of preparing the same

A compound of chemical formula I: or chemical formula II: or a pharmaceutical acceptable salt thereof is disclosed. R, R, R, and Rare independently H, halogen, nitro, hydroxyl, cyano, benzyloxy, C-Cstraight or branched alkyl, C1-C8 straight or branched haloalkyl, C-Cstraight or branched alkoxy.

Alantolactone/isoalantolactone spiro aryl isoxazoline compounds

A compound of chemical formula I: or formula II: or a pharmaceutical acceptable salt thereof is disclosed. Ris OH or OAc; X is C or N; and Ris H, alkyl, alkoxy, benzyloxy, haloalkyl, OH, CN, NO, or halogen, provided that when X is N, Ris nil.

1-O-acetylbritannilatone spiro aryl isoxazoline compounds

A compound having the following formula (I): is disclosed. A method of preparing the compound of formula (I) is also disclosed.

Bergenin thiodipropionic acid ester with antioxidant activity and a method of improving the antioxidant property of ganoderma lucidum spore oil using the same

A compound having the following formula I: is disclosed. A method of preparing the compound of formula (I) is also disclosed.

Dihydroxytyrosol hexamethylene-1,6-dicarbamate having antioxidant activity and a method of preparing the same

Hydroxytyrosol p-phenylenedicarboxylate having antioxidant activity and a method of preparing the same

Hydroxytyrosol isophorone diisocyannate derivative with antioxidant activity and a method of preparing the same

A compound having the following formula I: is disclosed. A method of preparing the compound of formula I is also disclosed.

Hydroxytyrosol thiodipropionic acid ester with antioxidant activity and a method of preparing the same

Hydroxytyrosol shikimic acid ester for treating cardiovascular deceases and a method of preparing the same

A compound having the following formula I: In formula I, Rand Rare independently H, alkyl, alkoxy, and halogen. A method of preparing the compound of formula I is also disclosed.

13-hydroxysparteine cinnamic acid derivatives with anti-tumor activities and a method of preparing the same

Growing community of inventors

Xi'an, China

Yuzhi Liu